The average age of men diagnosed with prostate cancer is falling, and thus the burden of morbidity associated with its treatment is of great interest. Physicians want to provide their patients with definitive cancer treatment, but without the morbidity which is associated with surgery and radiotherapy. Ablative therapy, using modalities such as high-frequency focused ultrasound (HIFU), offers an exciting prospect for in situ definitive treatment of prostate cancer, with a theoretical reduction in associated adverse effects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Draisma, G. et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J. Natl Cancer Inst. 101, 374–383 (2009).
Schroder, F. H. et al. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360, 1320–1328 (2009).
Hugosson, J. et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 11, 725–732 (2010).
Bill-Axelson, A. et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N. Engl. J. Med. 352, 1977–1984 (2005).
Emanuel, E. J. & Fuchs, V. R. The perfect storm of overutilization. JAMA 299, 2789–2791 (2008).
Crawford, E. D., Black, L., Eaddy, M. & Kruep, E. J. A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer. Prostate Cancer Prostatic Dis. 13, 162–167 (2010).
Crouzet, S. et al. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur. Urol. 58, 559–566 (2010).
Zapatero, A. et al. Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us? Eur. Urol. 55, 902–909 (2008).
Pollack, A. et al. Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57, 19–23 (2003).
Blana, A. et al. Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer. World J. Urol. 24, 585–590 (2006).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Ward, J. HIFU is effective, but associated morbidity still remains unclear. Nat Rev Urol 7, 597–598 (2010). https://doi.org/10.1038/nrurol.2010.176
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2010.176
